Assessment of the Public Health Benefit of artemisinin based combination therapies for uncomplicated malaria treatment in Mali
1. To test the hypothesis that repeated administration of artesunate+amodiaquine (AS+AQ (Arsucam)), artesunate plus sulphadoxine-pyrimethamine (AS/SP) and artemether-lumefantrine (AR-L (Coartem)) for treatment of consecutive episodes of uncomplicated malaria reduces the incidence of uncomplicated malaria 2. To measure the impact of repeated administration of the drugs on malarial immunity and malaria transmission
Department | Institution | Country |
---|---|---|
Malaria Research & Training Center | Mali |
TA.2004.40200.003
EDCTP1
Senior Fellowship (SF)
Phase IV Randomised Control Trial